HAWKHILL THERAPEUTICS Ltd research brief

CIK 2140690 Copy CIK

Generated Nov. 11, 2026, 8:56 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: DUNDEE, SCOTLAND X0. Reported legal jurisdiction: UNITED KINGDOM. These do not establish investor residence or where funds were deployed.

• Sept. 29, 2026 · D/A · 0002140690-26-000002 · Source evidence

  Reported offering amount: 290530 USD. Reported amount sold: 290530 USD.

• June 23, 2026 · D · 0002140690-26-000001 · Source evidence

  Reported offering amount: 192569 USD. Reported amount sold: 192569 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “HAWKHILL THERAPEUTICS Ltd research brief,” CIK 2140690, retrieved Nov. 11, 2026, 8:56 a.m.. Cite the specific accessions used. No amounts have been summed.